Company intelligence / Profile preview

Pond Technologies

Markham, Ontario, Canadapondtech.com ↗

Ownership: Private
Development stage: Other

Overview

Pond Technologies has developed a proprietary algae-based biomanufacturing platform that enables the cost-effective production of complex recombinant proteins—including antibodies—for use in diagnostics and therapeutics. The company’s biotech division focuses on contract manufacturing rather than developing its own clinical pipeline. No direct clinical results have been published as the business model centers on enabling partners’ R&D/manufacturing needs.

Modalities: Recombinant proteinProteinAntibody
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Pond Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pond Technologies.

Explore the full profile